поздравления с днём рождения женщине потерявшей сына
Главное меню:
Интересное
поздравления с днём рождения женщине потерявшей сына, Fluvestrant vs Letrozole FALCON TRIAL - Breast Cancer - Inspire, Aromatase Inhibitors — What to expect? - Breast cancer - Inspire, Has anyone had to stop aromatese inhibitors because they - Inspire, 5 years vs. 10 years aromatase inhibitors for breast cancer, Aromatase Inhibitor Neuropathy - Breast Cancer - Inspire, Ibrance and faslodex what is next? - Breast Cancer - Inspire, Does anyone take Milk thistle? Whats docs opinion?.
Thanks for highlighting this...I read the report of this a few days ago and have ben pondering the implications ...I had a conversation with my onc about the practical application of this finding...After saying that it would have no direct impact on MY treatment plan, since I already have had nearly 2 years on an AI, she did say she was not surprised...But what she really would like to see is "What is the impact on overall treatment plans and response after the cancer cells develop resistance to fulvestrant?" Typically fulvestrant is a second-line approach due to the ER degradation effect, which in theory if used first would limit the second-line use of an AI following it, since blocking aromatase is moot in the face of no functional ER receptor--so she worries that despite prolonging PRS in the first-line, it might be shortening the total length of time an antihormal approach would be effective... and she notes that typically in the same treatment-naive population, we now (at least in the US) would most likely use an AI plus palbo or one of the soon-to-be-approved CDK4/6 inhibitors...for most patients AI monotherpay is not the best approach., Aromatase inhibitors are a standard of care for hormone receptor–positive locally advanced or metastatic breast cancer. FALCON is the first randomized, double-blind, multicenter trial to assess the efficacy and safety of monotherapy with the estrogen downregulator fulvestrant compared with aromatase inhibitors for a population of women with , I am 74 and am 5 yrs out from Stage 2 Lobular BC. I underwent a total mastectomy (due to large size of tumor in small breast), followed by 4 months of chemo. I was then started on Letrozole (one of the aromatase inhibitors AIs) to help prevent recurrence of the CA..
Aromatase inhibitors are a recent addition to the breast cancer arsenal and are now being used in place of tamoxifen, an older drug used to block the production of estrogen. Studies suggest the new medications are more effective in preventing a recurrence of the cancer but, given their side effects, tamoxifen might be the better choice for some , I am considering ending my 5 years of taking an aromatase inhibitor for breast cancer. Some say for early stage, no lymph nodes involved, radiation and lumpectomy that 5 years is enough. Others say 7-10. Has anyone had experience with this decision and what was your outcome. Many thanks for your feedback., I am terribly sorry to hear about your neuropathy. For many people on aromatase inhibitors, glucosamine HCI 1500 mg with Chondroitin Sulfate 1200 mg all in a single capsule at nighttime can help. I am wondering whether you may have seen a neurologist? It's possible that physical therapy or some other stimulation may be of help., • The combination of a CDK4/6 inhibitor such as Ibrance (Palbociclib), Kisqali (Ribociclib) or Verzenio (Abemaciclib) with either an Aromatase Inhibitor (Letrozole [Femara], Arimidex [Anastrozole], or Aromasin [Exemestane]) or with Faslodex (Fulvestrant) is the current standard-of-care as initial treatment. • An Aromatase Inhibitor alone., Just a quick heads-up: I was taking milk thistle while on Femara, an Aromatase Inhibitor (AI), and my Naturopathic Oncologist immediately advised me to stop taking it because it could interfere with the efficacy of the liver's ability to process the Femara (sorry, I don't remember the exact specifics)., Aromatase inhibitor-induced arthralgia: a review P. Niravath⇓ + Author Affiliations Medicine Department, Lester & Sue Smith Breast Center, Baylor College of Medicine, Houston,USA *Correspondence to: Dr P. Niravath, Internal Medicine, Baylor College of Medicine, One Baylor Plaza, BCM 660, Houston, TX 77030, USA..